Cargando…
Novel Insights into PARK7 (DJ-1), a Potential Anti-Cancer Therapeutic Target, and Implications for Cancer Progression
The expression of PARK7 is upregulated in various types of cancer, suggesting its potential role as a critical regulator of the pathogenesis of cancer and in the treatment of cancer and neurodegenerative diseases, including Parkinson’s disease, Alzheimer’s disease, and Huntington disease. PARK7 acti...
Autor principal: | Jin, Wook |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7288009/ https://www.ncbi.nlm.nih.gov/pubmed/32357493 http://dx.doi.org/10.3390/jcm9051256 |
Ejemplares similares
-
PARK7/DJ-1 in microglia: implications in Parkinson’s disease and relevance as a therapeutic target
por: Lind-Holm Mogensen, Frida, et al.
Publicado: (2023) -
PARK7/DJ-1 as a Therapeutic Target in Gut-Brain Axis Diseases
por: Pap, Domonkos, et al.
Publicado: (2022) -
Knockdown of the DJ-1 (PARK7) gene sensitizes pancreatic cancer to erlotinib inhibition
por: He, Xiangyi, et al.
Publicado: (2021) -
Differential effect of DJ-1/PARK7 on development of natural and induced regulatory T cells
por: Singh, Yogesh, et al.
Publicado: (2015) -
Maternal PARK7 (DJ-1) levels and the preterm premature rupture of membranes: Correspondence
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2022)